Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Publisher Correction: Rapid desolvation-triggered domino lattice rearrangement in a metal-organic framework.

Lo SH, Feng L, Tan K, Huang Z, Yuan S, Wang KY, Li BH, Liu WL, Day GS, Tao S, Yang CC, Luo TT, Lin CH, Wang SL, Billinge SJL, Lu KL, Chabal YJ, Zou X, Zhou HC.

Nat Chem. 2019 Dec 10. doi: 10.1038/s41557-019-0404-9. [Epub ahead of print]

PMID:
31822853
2.

Rapid desolvation-triggered domino lattice rearrangement in a metal-organic framework.

Lo SH, Feng L, Tan K, Huang Z, Yuan S, Wang KY, Li BH, Liu WL, Day GS, Tao S, Yang CC, Luo TT, Lin CH, Wang SL, Billinge SJL, Lu KL, Chabal YJ, Zou X, Zhou HC.

Nat Chem. 2019 Dec 2. doi: 10.1038/s41557-019-0364-0. [Epub ahead of print] Erratum in: Nat Chem. 2019 Dec 10;:.

PMID:
31792388
3.

Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With Dementia.

Day GS, Cruchaga C, Wingo T, Schindler SE, Coble D, Morris JC.

JAMA Netw Open. 2019 Oct 2;2(10):e1913491. doi: 10.1001/jamanetworkopen.2019.13491.

4.

Zirconium Phosphate: The Pathway from Turbostratic Disorder to Crystallinity.

Contreras-Ramirez A, Tao S, Day GS, Bakhmutov VI, Billinge SJL, Zhou HC.

Inorg Chem. 2019 Oct 21;58(20):14260-14274. doi: 10.1021/acs.inorgchem.9b02442. Epub 2019 Oct 7.

PMID:
31589438
5.

Testing for N-methyl-D-aspartate receptor autoantibodies in clinical practice.

Brooks J, Yarbrough ML, Bucelli RC, Day GS.

Can J Neurol Sci. 2019 Sep 30:1-27. doi: 10.1017/cjn.2019.305. [Epub ahead of print] No abstract available.

PMID:
31566162
6.

The thermally induced decarboxylation mechanism of a mixed-oxidation state carboxylate-based iron metal-organic framework.

Drake HF, Day GS, Vali SW, Xiao Z, Banerjee S, Li J, Joseph EA, Kuszynski JE, Perry ZT, Kirchon A, Ozdemir OK, Lindahl PA, Zhou HC.

Chem Commun (Camb). 2019 Nov 4;55(85):12769-12772. doi: 10.1039/c9cc04555d. Epub 2019 Sep 30.

PMID:
31565709
7.

Reader response: Unintended consequences of Mayo paraneoplastic evaluations.

Brier MR, Bucelli RC, Day GS.

Neurology. 2019 Sep 24;93(13):603. doi: 10.1212/WNL.0000000000008178. No abstract available.

PMID:
31551272
8.

Oculopalatal Tremor Following Pontine Hemorrhage.

Wilks A, McCullough A, Day GS.

Neurohospitalist. 2019 Oct;9(4):241-242. doi: 10.1177/1941874419826416. Epub 2019 Feb 7. No abstract available.

PMID:
31534617
9.

Ligand-Rearrangement-Induced Transformation from a 3D Supramolecular Network to a Discrete Octanuclear Cluster: A Good Detector for Pb2+ and Cr2O7 2.

Yang DD, Liu Y, Li S, Cheng L, Wang Y, Zhang YX, Chen K, Gao YX, Ren P, Day GS, Wang Y.

ACS Omega. 2019 Jul 1;4(7):11493-11499. doi: 10.1021/acsomega.9b00680. eCollection 2019 Jul 31.

10.

The chemistry of multi-component and hierarchical framework compounds.

Feng L, Wang KY, Day GS, Zhou HC.

Chem Soc Rev. 2019 Sep 16;48(18):4823-4853. doi: 10.1039/c9cs00250b. Review.

PMID:
31359020
11.

Modulation versus Templating: Fine-Tuning of Hierarchally Porous PCN-250 Using Fatty Acids To Engineer Guest Adsorption.

Kirchon A, Li J, Xia F, Day GS, Becker B, Chen W, Sue HJ, Fang Y, Zhou HC.

Angew Chem Int Ed Engl. 2019 Sep 2;58(36):12425-12430. doi: 10.1002/anie.201905006. Epub 2019 Aug 1.

PMID:
31265165
12.

Photosensitizer-Anchored 2D MOF Nanosheets as Highly Stable and Accessible Catalysts toward Artemisinin Production.

Wang Y, Feng L, Pang J, Li J, Huang N, Day GS, Cheng L, Drake HF, Wang Y, Lollar C, Qin J, Gu Z, Lu T, Yuan S, Zhou HC.

Adv Sci (Weinh). 2019 Apr 9;6(11):1802059. doi: 10.1002/advs.201802059. eCollection 2019 Jun 5.

13.

Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET Testing.

Armstrong MJ, Gronseth GS, Day GS, Rheaume C, Alliance S, Mullins CD.

Alzheimer Dis Assoc Disord. 2019 Jul-Sep;33(3):246-253. doi: 10.1097/WAD.0000000000000311.

PMID:
31058683
14.

Photoinduced Nonlinear Contraction Behavior in Metal-Organic Frameworks.

Shi YX, Chen HH, Zhang WH, Day GS, Lang JP, Zhou HC.

Chemistry. 2019 Jun 26;25(36):8543-8549. doi: 10.1002/chem.201900347. Epub 2019 May 27.

PMID:
31050058
15.

Sleep disturbances are common in patients with autoimmune encephalitis.

Blattner MS, de Bruin GS, Bucelli RC, Day GS.

J Neurol. 2019 Apr;266(4):1007-1015. doi: 10.1007/s00415-019-09230-2. Epub 2019 Feb 11.

PMID:
30741377
16.

Structural signature of sporadic Creutzfeldt-Jakob disease.

Navid J, Day GS, Strain J, Perrin RJ, Bucelli RC, Dincer A, Wisch JK, Soleimani-Meigooni D, Morris JC, Benzinger TLS, Ances BM.

Eur J Neurol. 2019 Aug;26(8):1037-1043. doi: 10.1111/ene.13930. Epub 2019 Mar 25.

PMID:
30735286
17.

Reversible Dementias.

Day GS.

Continuum (Minneap Minn). 2019 Feb;25(1):234-253. doi: 10.1212/CON.0000000000000688.

PMID:
30707195
18.

Uncovering Two Principles of Multivariate Hierarchical Metal-Organic Framework Synthesis via Retrosynthetic Design.

Feng L, Yuan S, Li JL, Wang KY, Day GS, Zhang P, Wang Y, Zhou HC.

ACS Cent Sci. 2018 Dec 26;4(12):1719-1726. doi: 10.1021/acscentsci.8b00722. Epub 2018 Dec 12.

19.

Author response: In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.

Day GS, Gordon BA, Perrin RJ, Ances BM.

Neurology. 2019 Jan 15;92(3):150. doi: 10.1212/WNL.0000000000006771. No abstract available.

PMID:
30643031
20.

Patient characteristics and outcome associations in AMPA receptor encephalitis.

Laurido-Soto O, Brier MR, Simon LE, McCullough A, Bucelli RC, Day GS.

J Neurol. 2019 Feb;266(2):450-460. doi: 10.1007/s00415-018-9153-8. Epub 2018 Dec 17.

PMID:
30560455
21.

Suspension Processing of Microporous Metal-Organic Frameworks: A Scalable Route to High-Quality Adsorbents.

Kirchon A, Day GS, Fang Y, Banerjee S, Ozdemir OK, Zhou HC.

iScience. 2018 Jul 27;5:30-37. doi: 10.1016/j.isci.2018.06.009. Epub 2018 Jul 11.

22.

Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions.

Day GS, Musiek ES, Morris JC.

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):291-297. doi: 10.1097/WAD.0000000000000276.

23.

Incorporating Heavy Alkanes in Metal-Organic Frameworks for Optimizing Adsorbed Natural Gas Capacity.

Fang Y, Banerjee S, Joseph EA, Day GS, Bosch M, Li J, Wang Q, Drake H, Ozdemir OK, Ornstein JM, Wang Y, Lu TB, Zhou HC.

Chemistry. 2018 Nov 16;24(64):16977-16982. doi: 10.1002/chem.201804012. Epub 2018 Oct 26.

PMID:
30203519
24.

Author response: Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Aug 21;91(8):373-374. doi: 10.1212/WNL.0000000000006042. No abstract available.

PMID:
30126885
25.

Identifying priority outcomes that influence selection of disease-modifying therapies in MS.

Day GS, Rae-Grant A, Armstrong MJ, Pringsheim T, Cofield SS, Marrie RA.

Neurol Clin Pract. 2018 Jun;8(3):179-185. doi: 10.1212/CPJ.0000000000000449.

26.

Exposed Equatorial Positions of Metal Centers via Sequential Ligand Elimination and Installation in MOFs.

Yuan S, Zhang P, Zhang L, Garcia-Esparza AT, Sokaras D, Qin JS, Feng L, Day GS, Chen W, Drake HF, Elumalai P, Madrahimov ST, Sun D, Zhou HC.

J Am Chem Soc. 2018 Aug 29;140(34):10814-10819. doi: 10.1021/jacs.8b04886. Epub 2018 Aug 21.

PMID:
30089362
27.

Discovery and validation of autosomal dominant Alzheimer's disease mutations.

Hsu S, Gordon BA, Hornbeck R, Norton JB, Levitch D, Louden A, Ziegemeier E, Laforce R Jr, Chhatwal J, Day GS, McDade E, Morris JC, Fagan AM, Benzinger TLS, Goate AM, Cruchaga C, Bateman RJ; Dominantly Inherited Alzheimer Network (DIAN), Karch CM.

Alzheimers Res Ther. 2018 Jul 18;10(1):67. doi: 10.1186/s13195-018-0392-9.

28.

Autoimmune Dementia.

Long JM, Day GS.

Semin Neurol. 2018 Jun;38(3):303-315. doi: 10.1055/s-0038-1660480. Epub 2018 Jul 16. Review.

PMID:
30011411
29.

Long-Term Cognitive Outcomes in Patients with Autoimmune Encephalitis.

Hébert J, Day GS, Steriade C, Wennberg RA, Tang-Wai DF.

Can J Neurol Sci. 2018 Sep;45(5):540-544. doi: 10.1017/cjn.2018.33. Epub 2018 Jun 25.

PMID:
29936915
30.

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345. Review. Erratum in: Neurology. 2019 Oct 22;93(17):769.

PMID:
29686117
31.

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347. Erratum in: Neurology. 2019 Jan 8;92(2):112.

PMID:
29686116
32.

Autoimmune Encephalitis With Multiple Autoantibodies: A Diagnostic and Therapeutic Challenge.

Kim AE, Kang P, Bucelli RC, Ferguson CJ, Schmidt RE, Varadhachary AS, Day GS.

Neurologist. 2018 Mar;23(2):55-59. doi: 10.1097/NRL.0000000000000171.

PMID:
29494437
33.

Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.

Warikoo N, Brunwasser SJ, Benz A, Shu HJ, Paul SM, Lewis M, Doherty J, Quirk M, Piccio L, Zorumski CF, Day GS, Mennerick S.

J Neurosci. 2018 Mar 28;38(13):3218-3229. doi: 10.1523/JNEUROSCI.3377-17.2018. Epub 2018 Feb 23.

34.

In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.

Day GS, Gordon BA, Perrin RJ, Cairns NJ, Beaumont H, Schwetye K, Ferguson C, Sinha N, Bucelli R, Musiek ES, Ghoshal N, Ponisio MR, Vincent B, Mishra S, Jackson K, Morris JC, Benzinger TLS, Ances BM.

Neurology. 2018 Mar 6;90(10):e896-e906. doi: 10.1212/WNL.0000000000005064. Epub 2018 Feb 7.

35.

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.

36.

Teaching NeuroImages: Cerebral amyloid angiopathy-related inflammation presenting with isolated leptomeningitis.

Kang P, Bucelli RC, Ferguson CJ, Corbo JC, Kim AH, Day GS.

Neurology. 2017 Aug 8;89(6):e66-e67. doi: 10.1212/WNL.0000000000004218. No abstract available.

PMID:
28784645
37.

Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia.

Day GS, Gordon BA, Jackson K, Christensen JJ, Rosana Ponisio M, Su Y, Ances BM, Benzinger TLS, Morris JC.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):87-93. doi: 10.1097/WAD.0000000000000196.

38.

Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease.

Day GS, Lim TS, Hassenstab J, Goate AM, Grant EA, Roe CM, Cairns NJ, Morris JC.

Neurology. 2017 Mar 28;88(13):1273-1281. doi: 10.1212/WNL.0000000000003770. Epub 2017 Feb 24.

39.

Rethinking Outcomes in Leucine-Rich, Glioma-Inactivated 1 Protein Encephalitis: "Good" Isn't Good Enough.

Day GS.

JAMA Neurol. 2017 Jan 1;74(1):19-21. doi: 10.1001/jamaneurol.2016.4538. No abstract available.

PMID:
27893010
40.

A Case Study in the History of Neurology.

Day GS, Tang-Wai DF, Shamy MC.

Neurohospitalist. 2016 Oct;6(4):181-184. Epub 2016 May 27.

41.

Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease: A Single-Family Case-Control Study.

Day GS, Musiek ES, Roe CM, Norton J, Goate AM, Cruchaga C, Cairns NJ, Morris JC.

JAMA Neurol. 2016 Sep 1;73(9):1125-32. doi: 10.1001/jamaneurol.2016.1236.

43.

Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?

Fischer CE, Golas AC, Schweizer TA, Munoz DG, Ismail Z, Qian W, Tang-Wai DF, Rotstein DL, Day GS.

Expert Rev Neurother. 2016 Jul;16(7):849-59. doi: 10.1080/14737175.2016.1184088. Epub 2016 May 17. Review.

PMID:
27123777
44.

N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI.

Brier MR, Day GS, Snyder AZ, Tanenbaum AB, Ances BM.

J Neurol. 2016 Jun;263(6):1083-91. doi: 10.1007/s00415-016-8083-6. Epub 2016 Mar 30.

45.

Teaching NeuroImages: Recurrent SSPE presenting as Anton syndrome with cortical ribboning.

Day GS, Tai P, Moharir M, Tang-Wai DF.

Neurology. 2015 Nov 10;85(19):e141-2. doi: 10.1212/WNL.0000000000002096. No abstract available.

46.

GRIN1 polymorphisms do not affect susceptibility or phenotype in NMDA receptor encephalitis.

Day GS, Prüss H, Benseler SM, Paton TA, Paterson AD, Andrade DM.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e153. doi: 10.1212/NXI.0000000000000153. eCollection 2015 Oct.

47.

Fanning the Flames in Anti-N-methyl-D-aspartate Receptor Encephalitis.

Day GS, Munoz DG.

Int J Gynecol Pathol. 2015 Jul;34(4):401-2. doi: 10.1097/PGP.0000000000000186. No abstract available.

PMID:
26068021
48.

Cognitive decline in an older physician.

Day GS, Carette S, Tang-Wai DF.

CMAJ. 2015 Jul 14;187(10):750-754. doi: 10.1503/cmaj.140589. Epub 2015 Mar 30. No abstract available.

49.

Thiamine prescribing practices within university-affiliated hospitals: a multicenter retrospective review.

Day GS, Ladak S, Curley K, Farb NA, Masiowski P, Pringsheim T, Ritchie M, Cheung A, Jansen S, Methot L, Neville HL, Bates D, Lowe D, Fernandes N, Ferland A, Martin del Campo C.

J Hosp Med. 2015 Apr;10(4):246-53. doi: 10.1002/jhm.2324. Epub 2015 Feb 3.

PMID:
25652810
50.

Abnormal neurons in teratomas in NMDAR encephalitis.

Day GS, Laiq S, Tang-Wai DF, Munoz DG.

JAMA Neurol. 2014 Jun;71(6):717-24. doi: 10.1001/jamaneurol.2014.488.

PMID:
24781184

Supplemental Content

Support Center